Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor, MMP2 activity and HSP27 expression
Shelly Tartakover‐Matalon(PharmacoGenetics (China)), Michael Lishner(Tel Aviv University), Ami Fishman(Tel Aviv University), N. Cherepnin, Meir Pomeranz(Meir Medical Center), Liat Drucker(Meir Medical Center), Marina Kuchuk, Irina Kenis(Meir Medical Center)
Cited by 20
Related Papers
High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
|European Journal of Surgical Oncology|2006|63
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
|The FASEB Journal|2007|56
Simvastatin has deleterious effects on human first trimester placental explants
|Human Reproduction|2005|51
Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation
|Tumor Biology|2015|48
BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
|International Journal of Gynecological Cancer|2010|47